World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
128
Citations
192731
World Ranking
2630
National Ranking
272

Overview

Rury R. Holman is affiliated with the University of Oxford in the United Kingdom. Their research primarily lies within the field of Medicine, with a significant focus on Endocrinology, Diabetes and Metabolism, as well as Cardiology and Cardiovascular Medicine. Holman's work also spans Surgery, Molecular Biology, and Physiology.

The scientist's research topics cover various aspects of diabetes treatment and management, alongside cardiovascular function and associated risk factors. The main topics of their work include:

  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Cardiovascular Function and Risk Factors
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pancreatic function and diabetes
  • Diet and metabolism studies
  • Heart Rate Variability and Autonomic Control

Holman has contributed to several recent papers, reflecting collaborations with researchers in cardiovascular medicine and diabetes. Notable publications include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021, The Lancet)
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021, The Lancet)
  • Empagliflozin in acute myocardial infarction: the EMMY trial (2022, European Heart Journal)
  • Historical HbA1c Values May Explain the Type 2 Diabetes Legacy Effect: UKPDS 88 (2021, Diabetes Care)
  • Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II) (2020, Cardiovascular Diabetology)

Frequent coauthors in Holman's work include Ruth L. Coleman, Robert J. Mentz, Naveed Sattar, John B. Buse, and Adrian F. Hernandez, with collaboration counts ranging from 22 to 33 publications each. This indicates ongoing partnerships in research activities related to their fields of study.

The scientist has published extensively in several academic journals, with the highest number of publications appearing in:

  • Circulation (12 publications)
  • Diabetes Care (11 publications)
  • UNC Libraries (9 publications)
  • Diabetes Obesity and Metabolism (9 publications)
  • Cardiovascular Diabetology (7 publications)

Best Publications

  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

    R C Turner;R R Holman;C A Cull;I M Stratton

  • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

    R Turner;C Fox;Matthews;H McElroy

  • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

    Irene M Stratton;Amanda I Adler;H Andrew W Neil;David R Matthews

  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

    R C Turner;R R Holman;I M Stratton;C A Cull

  • 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

    Rury R. Holman;Sanjoy K. Paul;M. Angelyn Bethel;David R. Matthews

  • Definition of Metabolic Syndrome Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

    Scott M. Grundy;H. Bryan Brewer;James I. Cleeman;Sidney C. Smith

  • Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    David M. Nathan;John B. Buse;Mayer B. Davidson;Ele Ferrannini

  • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

    UK Prospective Diabetes;RR Holman;SE Manley;R Turner

  • International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial.

    Andrew Molyneux;Richard Kerr;Irene Stratton

  • Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

    Kahn Se;Haffner Sm;Heise Ma;Herman Wh

  • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

    R C Turner;C A Cull;V Frighi;R R Holman

  • International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

    David M. Nathan;Beverly Balkau;Enzo Bonora;Knut Borch-Johnsen

  • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

    R Turner;R Holman

  • Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

    A. I. Adler;I. M. Stratton;H. A. W. Neil;J. S. Yudkin

  • Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

    Jennifer B Green;M. Angelyn Bethel;Paul W Armstrong;John B Buse

  • Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

    R C Turner;H Millns;H A W Neil;I M Stratton

  • U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease

    R C Turner;C A Cull;I M Stratton;S E Manley

  • Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

    Amanda I. Adler;Richard J. Stevens;Sue E. Manley;Rudy W. Bilous

  • Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.

    rosiglitazone Medication Trial Investigators;H C Gerstein;S Yusuf

  • Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

    Rury R. Holman;M. Angelyn Bethel;Robert J. Mentz;Vivian P. Thompson

Frequent Co-Authors

John B. Buse
John B. Buse University of North Carolina at Chapel Hill
John J.V. McMurray
John J.V. McMurray University of Glasgow
Alastair Gray
Alastair Gray University of Oxford
Eric D. Peterson
Eric D. Peterson The University of Texas Southwestern Medical Center
Steven M. Haffner
Steven M. Haffner The University of Texas Health Science Center at San Antonio
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
Adrian F. Hernandez
Adrian F. Hernandez Duke University
Andrew T. Hattersley
Andrew T. Hattersley University of Exeter
Ewan R. Pearson
Ewan R. Pearson University of Dundee

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If traditional medical school isn't the right fit, or you’re seeking flexible education options, a variety of online degrees can open doors to rewarding healthcare careers. Many accredited universities now offer degree programs that blend online coursework with clinical experience, making it easier to advance in the medical field while managing work or family commitments.

Aspiring nurse leaders can consider the best DNP programs online, providing advanced practice knowledge and leadership skills. For those interested in medications and patient care, an online pharmacy degree is a flexible option that prepares students for pharmacist licensure.

For a technology-focused route, an online health information management degree can help launch or advance a career managing medical records and health data. Alternatively, if you’re looking for a shorter pathway into healthcare, consider the average cost of medical billing and coding program to enter the vital field of healthcare administration.

These online pathways offer diverse opportunities for those passionate about healthcare, even without a traditional MD path.

Best Scientists Citing Rury R. Holman

Trending Scientists